Prevalence and factor associated with Alcohol consumption behavior of patients with chronic hepatitis C virus (HCV) infection at Lomsak Hospital
Article Sidebar
Main Article Content
Abstract
This research aimed to study the prevalence and factors associated with alcohol consumption behavior of patients with chronic hepatitis C virus (HCV) infection at Lomsak Hospital. The cross-sectional study was designed. The sample were simple selected of 442 HCV patients with non anti-viral drugs treatment. Data was collected from September – December 2023 (Undated). Questionnaires were used including demographic data, knowledge about Hepatitis C virus Disease, Attitude about Alcohol consumption behavior, and The Alcohol Use Disorders Identification Test (AUDIT) for finding HCV patients who active drinking alcohol. Data were analyzed by statistics include frequency, percentages, Mean, S.D., Chi-square test, Odd ratio, with a significant level of 0.05. Results: The prevalence of Alcohol consumption behavior of patients with chronic HCV infection was 12.2 % (54 patients) included high risk drinker 74.1 % (40 patients) and low risk drinker 25.9 % (14 patients). The factors associated with Alcohol consumption behavior included Male (p = 0.021), Middle Age (40-59 yr.) (p<0.001), Couple Status (p<0.001), Primary school educated (p<0.001), Farmer (p=0.047), Income < 5000 Bath/Month (p<0.001) and High knowledge about Hepatitis C virus disease (p <0.001). Patients who have high score about Hepatitis C virus disease can decline risk of Alcohol consumption behavior for 87.1 (OR 0.129, 95% CI 0.048 – 0.353) (p<0.001), but level of the attitude about Alcohol consumption behavior not associated with Alcohol consumption behavior (OR 0.712, 95% CI 0.231 – 2.192) (p=0.289) Conclusion: There for ,The health care system and public policy should to provide and improve the treatment guideline for action and protection HCV patients who active drinking alcohol for better quality of life and decline complications and mortality of HCV patient with Alcohol consumption and accomplish of WHO achievement for eradication of HCV disease within 2030 BC.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright notice
Article published in the Journal of Disease and Health Risk DPC.3 Nakhon Sawan. It is considered a work of academic research and analysis as well as the personal opinion of the author. It is not the opinion of the Office of Disease Prevention and Control 3, Nakhon Sawan. Or the editorial team in any way Authors are responsible for their articles.
Privacy Policy
Name, address and e-mail address specified in the Journal of Disease and Health Risk DPC.3 Nakhon Sawan. It is used for identification purposes of the journal. And will not be used for any other purpose. Or to another person.
References
Pawlotsky JM, Feld JJ, Zeuzem S, Hoofnagle JH. From non-A, non-B hepatitis to hepatitis C virus cure. J Hepatol. 2015;62:S87-99.
Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3(2):47-52.
Westbrook, Rachel H. et al. Natural history of hepatitis C, Journal of Hepatology,2014;58 – 68.
Department of Disease Control. 2022 – 2030 Thailand National Strategies to Eliminate. L. Disease Control Journal 2021;4-34.
Cui F, Blach S, Manzengo MC, Gonzalez MA, Sabry AA, Mozalevskis A, et al. Global reporting of progress towards elimination of hepatitis B and hepatitis C. Lancet Gastroenterol Hepatol. 2023;8(4):332-342.
Napaporn P., Rujipat W., Khuandao T., Yong P. Nawarat P., Prevalence and risk factors of Hepatitis C virus in Phetchabun. Disease Control Journal. 2020; 8(3):28-40.
Kessaraporn Mongkolwaj. The development of self-health management system for hepatitis C infection patients during waiting for the treatment process at Lomsak hospital. Academic Journal of Phetchabun hospital 2022;1:1-18.
Thai Association for the Study of the Liver.Thailand Guideline for Management of Hepatocellular Carcinoma 2021. Bangkok; 2564;15-52.
Thai Association for the Study of the Liver. Thailand Practice Guideline for Management of Chronic Hepatitis C 2018. Bangkok; 2019;8-10.
Drugs for Neglected Diseases initiative corparation. Public health guidance on the spread of hepatitis C By Drugs for Neglected Diseases initiative corparation 2565.Malaysia; 6-15.
Thai National drug information. National Drug Policies in Thailand 2022., Bangkok; 2022.
Leggio L, Mellinger JL. Alcohol use disorder in community management of chronic liver diseases. Hepatology. 2023 ;77(3):1006-1021.
Proeschold-Bell RJ, Evon DM, Makarushka C, Wong JB, Datta SK, Yao J, et all. The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial. Contemp Clin Trials. 2018 Sep;72:73-85.
Llamosas-Falcón L, Shield KD, Gelovany M, Manthey J, Rehm J. Alcohol use disorders and the risk of progression of liver disease in people with hepatitis C virus infection - a systematic review. Subst Abuse Treat Prev Policy. 2020 Jun 30;15(1):45.
Im, P.K., Millwood, I.Y., Kartsonaki, C. et al. Alcohol drinking and risks of liver cancer and non-neoplastic chronic liver diseases in China: a 10-year prospective study of 0.5 million adults. BMC Med 19, 216 (2021).
Center of Alcohol Studies,Department of Epidemiology, Prince of Songkla University, Report on the situation of alcohol control policy implementation in Thailand be 2008 - 2018. Bangkok; 2018
Rehm J, Patra J, Brennan A, Buckley C, Greenfield TK, Kerr WC, et al. The role of alcohol use in the aetiology and progression of liver disease: A narrative review and a quantification. Drug Alcohol Rev. 2021 ;40(7):1377-1386.
Sims OT, Oh H, Pollio DE, Hong BA, Pollio EW, North CS. Quality of Life, Functioning, and Coping in HCV Patients Continuing Versus Ceasing Alcohol Use. Health Promot Pract. 2020 ;21(6):1012-1017.
Center of Alcohol Studies,Department of Epidemiology, Prince of Songkla University, Patterns and trends in alcohol drinking behavior of the Thai population. Bangkok; 2018
Abassa KK, Wu XY, Xiao XP, Zhou HX, Wu YW, Bin, et al. Effect of alcohol on clinical complications of hepatitis virus-induced liver cirrhosis: a consecutive ten-year study. BMC Gastroenterology. 2022;22:1-11.
Sahanut Phisalwut, The Experience of Entering the Treatment Process in Chronic Hepatitis C patients with a History of Alcohol Drinking at Lomsak Hospital, Phetchabun Province. Academic Journal of Phetchabun hospital. 25663;3(1):49-60
Wayne W., D. Biostatistics: A foundation of analysis in the health sciences (6th ed.). John Wiley & Sons, Inc., 1995:180.
World Health Organization Department of Mental Health and Substance Dependence. The alcohol use disorders identification test: guidelines for use in primary care 2nd edition. Bangkok;2001.
Manthey J, Shield KD, Rylett M, Hasan OSM, Probst C, Rehm J (2019) Global alcohol exposure between 1990 and 2017 and forecasts until 2030:a modelling study. The Lancet 393, 2493-502.
Andreasson S, Chikritzhs T, Dangardt F, Holder H, Naimi T, Shrek A, Stock well T. Alcohol and society 2021: Alcohol and the coronavirus pandemic: individual,societal and policyperspective. Stockholm: Swedish Society of Nursing, SFAM, SAFF, CERA, The Swedish Society of Addiction Medicine, SIGHT, Movendi international & IOGT-NTO, 2021; 9-27.
Phadoongsit Chumnanborirak. Factors Associated with Alcohol Consumption among People in Community of Dong Bang Sub district, Na Dun District,Maha Sarakham Province. Regional Health Promotion Center 9 Journal; 16(2) 2022 :711-22.
Muthita Ponpaipan. Factors related to alcohol drinking behavior of nursing students in Chiang Rai Province. Community health development journal, Khon Kaen University. 2017; 5(1):77-90.
Phiangphim Punrasi, Narongsak Noosorn. Behavioral Factors that Relate to Alcohol Consumption among Women Farmers. Science and technology EAU Heritage journal 2019; 13(3):143-58.